智通财经APP讯,恩典生命科技(02112)发布截至2026年6月30日止6个月的中期业绩,集团收入414.4万美元,同比减少50.77%;股东应占亏损1187.6万美元,同比盈转亏;每股亏损0.79美仙。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.